Dallas-based DataBahn.ai has raised $17 million in Series A funding in a round led by Forgepoint Capital, with participation from S3 Ventures and returning investor GTM Capital, bringing the startup’s total capital raised to $19 million.
Dallas-based DataBahn.ai has raised $17 million in Series A funding in a round led by Forgepoint Capital, with participation from S3 Ventures and returning investor GTM Capital, bringing the startup’s total capital raised to $19 million.
EtiraRX, a Dallas-based developer of novel therapies for treatment-resistant cancers, raised $2.4 million in venture funding from undisclosed investors.
https://www.fundz.net/fundings/etirarx-funding-round-8ab949
A North Texas biotech with AI at its core is now a public company. Caris Life Sciences, founded in 2008 and headquartered in Irving, made its Nasdaq debut Wednesday under the ticker CAI, raising $494 million in its initial public
Founded in 2022, Emotive, raised a $2.75M Seed round. The ERP software is designed for the auto sales and independent finance industry with AI-driven automation.
https://www.fundz.net/fundings/emotive-software-funding-round-43d4e2
Zevo, the first peer-to-peer marketplace for electric vehicle (EV) sharing, has successfully raised $6 million in funding. The company will use the capital to expand its innovative contactless rental platform into major U.S. cities.
https://theevreport.com/zevo-secures-6m-for-ev-sharing-platform
xpflow, a provider of an AI-powered operating system for affiliate management tasks, raises a $3.5M Seed round.
Co-founded by Chief Scientific Advisor Daniel J. Siegwart of UT Southwestern and CEO RA Session II, Signify Bio said it harnesses the human body for the production of in situ protein therapeutics. The round was led by Actium Group with
Aerones, the world’s leading provider of robotic inspection, maintenance, and AI-driven solutions for wind turbines, today announces that it has secured $62 million in capital in a significantly oversubscribed financing to accelerate its global expansion and technology development.
https://aerones.com/aerones-secures-62m-in-oversubscribed-financing-round/
Dallas-based OncoNano, raised a $12.7 million Series B venture funding from undisclosed investors. The company is developing a nanotechnology platform to enhance the effectiveness of cancer therapies in acidic tumor environments.